Clinical validation and utility of Percepta GSC for the evaluation of lung cancer

The Percepta Genomic Sequencing Classifier (GSC) was developed to up-classify as well as down-classify the risk of malignancy for lung lesions when bronchoscopy is non-diagnostic. We evaluated the performance of Percepta GSC in risk re-classification of indeterminate lung lesions. This multicenter s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzone, Peter, Dotson, Travis, Wahidi, Momen M., Bernstein, Michael, Lee, Hans J., Feller Kopman, David, Yarmus, Lonny, Whitney, Duncan, Stevenson, Christopher, Qu, Jianghan, Johnson, Marla, Walsh, P. Sean, Huang, Jing, Lofaro, Lori R., Bhorade, Sangeeta M., Kennedy, Giulia C., Spira, Avrum, Rivera, M. Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278743/
https://www.ncbi.nlm.nih.gov/pubmed/35830375
http://dx.doi.org/10.1371/journal.pone.0268567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278743/
https://www.ncbi.nlm.nih.gov/pubmed/35830375
http://dx.doi.org/10.1371/journal.pone.0268567

Ejemplares similares